Menu
GeneBe

SLC17A7

solute carrier family 17 member 7, the group of Solute carrier family 17

Basic information

Region (hg38): 19:49429400-49442360

Links

ENSG00000104888NCBI:57030OMIM:605208HGNC:16704Uniprot:Q9P2U7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC17A7 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC17A7 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
3
clinvar
4
missense
16
clinvar
1
clinvar
1
clinvar
18
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 16 2 5

Variants in SLC17A7

This is a list of pathogenic ClinVar variants found in the SLC17A7 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-49430529-C-T Likely benign (Jan 01, 2023)2650241
19-49430542-G-A not specified Uncertain significance (Oct 12, 2022)2227382
19-49430554-G-A Uncertain significance (Dec 01, 2016)808618
19-49430575-C-T not specified Uncertain significance (Oct 29, 2021)2214828
19-49430591-G-T Benign (Apr 06, 2018)741533
19-49430598-G-C not specified Uncertain significance (Sep 26, 2022)2374959
19-49430611-G-A not specified Uncertain significance (Mar 16, 2022)2352630
19-49430638-T-C not specified Uncertain significance (Jun 07, 2024)3318987
19-49430668-C-T not specified Uncertain significance (Jul 19, 2022)2302337
19-49430689-C-T not specified Uncertain significance (Jan 23, 2024)3163204
19-49430690-G-A Benign (Jun 13, 2018)727740
19-49430725-C-T not specified Uncertain significance (Jan 10, 2022)2271555
19-49431395-C-T not specified Uncertain significance (Nov 30, 2022)2329703
19-49431439-A-G not specified Uncertain significance (Oct 26, 2021)2257286
19-49432602-G-T not specified Uncertain significance (Jan 09, 2024)3163203
19-49432916-G-C Likely benign (Apr 01, 2023)2650242
19-49433716-G-T Benign (Jun 13, 2018)738168
19-49433817-G-C not specified Uncertain significance (Nov 21, 2022)2328812
19-49433830-C-T not specified Uncertain significance (Aug 26, 2022)2383269
19-49433865-C-T not specified Uncertain significance (Sep 01, 2021)2406302
19-49434053-G-A Benign (Apr 06, 2018)722306
19-49434613-G-A not specified Uncertain significance (Mar 29, 2023)2531132
19-49434679-T-G not specified Uncertain significance (Apr 01, 2024)3318989
19-49435203-T-C Benign (Mar 29, 2018)730241
19-49436665-T-C not specified Uncertain significance (Oct 18, 2021)2359396

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC17A7protein_codingprotein_codingENST00000221485 1212960
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.000117125742041257460.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.491783660.4870.00002143631
Missense in Polyphen1381.2520.16787
Synonymous0.02711571570.9970.00001041135
Loss of Function4.70025.80.000.00000110285

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005450.0000544
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.00005450.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mediates the uptake of glutamate into synaptic vesicles at presynaptic nerve terminals of excitatory neural cells. May also mediate the transport of inorganic phosphate. {ECO:0000269|PubMed:10820226}.;
Pathway
Synaptic vesicle cycle - Homo sapiens (human);Retrograde endocannabinoid signaling - Homo sapiens (human);Glutamatergic synapse - Homo sapiens (human);Nicotine addiction - Homo sapiens (human);Synaptic Vesicle Pathway;Organic anion transporters;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Neuronal System;Histidine metabolism;Glutamate Neurotransmitter Release Cycle;Neurotransmitter release cycle;Transmission across Chemical Synapses (Consensus)

Recessive Scores

pRec
0.250

Intolerance Scores

loftool
0.135
rvis_EVS
-0.31
rvis_percentile_EVS
31.93

Haploinsufficiency Scores

pHI
0.227
hipred
Y
hipred_score
0.799
ghis
0.585

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.114

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc17a7
Phenotype
growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
slc17a7a
Affected structure
eye
Phenotype tag
abnormal
Phenotype quality
decreased size

Gene ontology

Biological process
neural retina development;ion transport;phosphate ion transport;brain development;long-term memory;glutamate secretion;L-glutamate transmembrane transport;synaptic transmission, glutamatergic;sodium ion transmembrane transport;sequestering of neurotransmitter;sodium-dependent phosphate transport;regulation of synapse structure or activity;L-glutamate import;excitatory postsynaptic potential;synaptic vesicle lumen acidification;neurotransmitter loading into synaptic vesicle;regulation of synaptic vesicle endocytosis;chloride transmembrane transport
Cellular component
plasma membrane;integral component of membrane;cell junction;integral component of synaptic vesicle membrane;synaptic vesicle membrane;cerebellar mossy fiber;presynaptic active zone;excitatory synapse;clathrin-sculpted glutamate transport vesicle membrane;postsynapse
Molecular function
L-glutamate transmembrane transporter activity;neurotransmitter transporter activity;extracellularly glutamate-gated chloride channel activity;sodium:inorganic phosphate symporter activity;sodium-dependent phosphate transmembrane transporter activity